Medical News Today -
22 Oct 2013 11:00
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults[i]. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products...
Share this Article